Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPyQ: PQQ for Obese Pregnancy Outcomes
NCT06245083Phase 1Withdrawn
- Sponsor
- University of Oklahoma
- Start
- Dec 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity comparing PQQ Supplement with Placebo (2 arms). Primary endpoints: Leptin, Adiponectin and 18 more. Planned start Dec 2024; status: withdrawn.
02
Drugs
pyrroloquinoline quinone
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06245083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06245083.